Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Personal Genome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10486
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

Personal Genome Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Personal Genome Diagnostics Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11
Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13
Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14
Personal Genome Diagnostics Raises US$2.8 Million In Venture Financing 15
Personal Genome Diagnostics Raises US$2 Million In Venture Financing 16
Private Equity 17
Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17
Partnerships 18
Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18
Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19
Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23
Cure Forward Enters into Agreement with Personal Genome Diagnostics 24
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26
Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27
Personal Genome Diagnostics Inc – Key Competitors 28
Personal Genome Diagnostics Inc – Key Employees 29
Personal Genome Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Recent Developments 31
Corporate Communications 31
Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 31
Product News 32
Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 32
Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 33
Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 34
Jan 04, 2017: Personal Genome Diagnostics ImmunoSELECT Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study 35
Other Significant Developments 36
Sep 05, 2018: Machine learning approach by Personal Genome Diagnostics outperforms existing mutation detection methods according to study in Science Translational Medicine 36
Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Personal Genome Diagnostics Inc, Medical Equipment, Key Facts 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Personal Genome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Personal Genome Diagnostics Raises USD75 Million in Series B Financing 11
Personal Genome Diagnostics Raises USD65.4 Million in Venture Financing 13
Personal Genome Diagnostics Raises USD4.3 Million in Venture Financing 14
Personal Genome Diagnostics Raises US$2.8 Million In Venture Financing 15
Personal Genome Diagnostics Raises US$2 Million In Venture Financing 16
Innovatus Capital Partners to Invest up to USD42 Million in Personal Genome Diagnostics 17
Personal Genome Diagnostics Enters into Licensing Agreement with Memorial Sloan Kettering Cancer 18
Personal Genome Diagnostics Enters into Licensing Agreement with Johns Hopkins University 19
Personal Genome Diagnostics Enters into Licensing Agreement with Human Longevity 20
QIAGEN Enters Into Licensing Agreement With Personal Genome Diagnostics 21
Personal Genome Diagnostics Enters into Agreement Five Prime Therapeutics 22
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 23
Cure Forward Enters into Agreement with Personal Genome Diagnostics 24
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 25
Personal Genome Diagnostics Enters Into Co-Development Agreement With Blueprint Medicines For Novel Kinase Targets 26
Personal Genome Enters Into Licensing Agreement With Johns Hopkins University 27
Personal Genome Diagnostics Inc, Key Competitors 28
Personal Genome Diagnostics Inc, Key Employees 29

List of Figures
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Personal Genome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Personal Genome Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fremont Michigan InsuraCorp Inc.:企業の戦略・SWOT・財務情報
    Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Mitsubishi International Food Ingredients, Inc.:戦略・SWOT・企業財務分析
    Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Intercede Group plc (IGP):企業の財務・戦略的SWOT分析
    Intercede Group plc (IGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SGS SA (SGSN):電力:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Laing O’Rourke Australia Pty Ltd:企業の戦略的SWOT分析
    Laing O'Rourke Australia Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • DaVita Inc.:企業の戦略・SWOT・財務情報
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Willamette Valley Vineyards, Inc.:企業の戦略・SWOT・財務情報
    Willamette Valley Vineyards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Willamette Valley Vineyards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Engie SA (ENGI)-石油・ガス分野:企業M&A・提携分析
    Summary Engie S.A. (Engie), formerly GDF Suez S.A., is an electric utility, which generates and distributes electricity and natural gas. It generates electricity using various sources including hydro, wind, solar, biomass, geothermal, nuclear, coal and fuel oil. The company supplies, distributes, tr …
  • Anergis SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Anergis SA (Anergis) is a clinical stage biopharmaceutical company that discovers, develops and markets immunotherapy products. The company uses synthetic, pharmaceutical-grade contiguous overlapping peptide to derive allergy immunotherapeutics from its proprietary long peptide technology pl …
  • Eaton Vance Corp:企業の戦略・SWOT・財務分析
    Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report Summary Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, m …
  • Best Buy Co, Inc.:企業のM&A・事業提携・投資動向
    Best Buy Co, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Best Buy Co, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Air France-KLM SA:戦略・SWOT・企業財務分析
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • ITOCHU Corporation:企業の戦略・SWOT・財務情報
    ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report Summary ITOCHU Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Health Care Service Corp:企業の戦略的SWOT分析
    Health Care Service Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Unum Therapeutics Inc (UMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務分析
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆